- MeVis Medical Solutions
- Investor Relations
- Investor News
- MeVis Investor News 1/2011
Bremen, January 18, 2011 – MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading company in medical imaging software, today announced a change in their Supervisory Board.
PDF-Download of this release
Upon request of the Executive Board of the MeVis Medical Solutions AG, Dr. Jens J. Kruse, head of Corporate Finance at the private bank M.M.Warburg & CO in Hamburg, Germany, has, with immediate effect, been appointed into the control committee by the local court of Bremen. Axel Schubert has resigned his position as vice-chairman of the Supervisory Board for personal reasons as of 31 December 2010. The appointment of Dr. Kruse as alternate member is limited until this year’s annual general meeting, which will on a rotational basis decide on the re-composition of the Supervisory Board.
"With Dr. Jens Kruse, we have gained an experienced manager in the capital market and financial world, who has closely accompanied us since our initial public offering. We look forward to the cooperation", says Dr. Carl. J. G. Evertsz, chairman of the MeVis Medical So-lutions AG Executive Board. Furthermore, the Executive and Supervisory Board both ex-pressed their gratitude to Axel Schubert, who has retired from the control committee, for his faithful and long-term cooperation.
The Supervisory Board of the MeVis Medical Solutions AG consists of Dr. Jens Kruse to-gether with Prof. Dr. Heinz-Otto Peitgen and Dr. Peter Zencke.
For further information please visit http://www.mevis.de.
MeVis Medical Solutions AG was founded in 1997 and is one of the world’s leading independent manufacturers and vendors of medical imaging software with focus on dedicated, disease-oriented clinical applications. Over the past few years, there has been an enormous increase in the complexity and volume of medical imaging data derived from digital imaging processes such as computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound (US). MeVis Group’s products analyze and process this data in such a way as to provide medical professionals with crucial information for early detection, diagnosis and intervention in the areas of cancer and lung diseases as well as neurological conditions. The Group develops its software solutions in close consultation with the world’s leading medical experts and original equipment makers in the medical technology sector and primarily markets this software via these partnerships.
Click on the MeVis image for access to the online archive of our Investor Relations Newsletters.
| 2011-04-11 through 2011-04-13 | 3rd Small Cap Forum, Frankfurt am Main |
| 2011-04-19 | Consolidated financial statement fiscal 2010 |
| 2011-05-30 | Interim report first quarter of fiscal 2011 |
| 2011-06-15 | Annual General Meeting, Bremen |
| 2011-08-29 | Interim report second quarter and first half of fiscal 2011 |
| 2011-08-29 through 2011-08-31 | 9th DVFA-Small Cap Conference, Frankfurt am Main |
| 2011-11-21 | Interim report third quarter and first nine months of fiscal 2011 |
| 2011-11-21 through 2011-11-23 | German Equity Forum, Frankfurt am Main |
MeVis Medical Solutions AG
Dr. Kai Holtmann
Investor Relations Manager
Universitaetsallee 29
28359 Bremen
Germany
Phone: +49 421 22495 - 63
Fax: +49 421 22495 - 11
E-Mail: ir[at]mevis.de
